Steris Plc experienced a mixed performance lately, with the stock sometimes underperforming compared to its competitors but still hitting a new 52-week high. Many investment firms like Artemis Investment Management LLP, Global Assets Advisory LLC, and Fisher Asset Management LLC have increased their stakes, and new stakes have been acquired by Opal Wealth Advisors LLC and Mather Group LLC among others. Steris has also witnessed insider stock sales by its SVP and President, Healthcare, Cary Majors. On the earnings front, the Q4 and Q3 2024 earnings calls recorded and Q3 Fiscal 2024 result shows strong growth in revenue and earnings. However, despite strong financials, the market sentiment is mixed due to mixed fundamentals. The company seems to be focusing on growth initiatives and a variety of new offerings. However, they are faced with macro issues and plans for restructuring, including plant closures in Brazil and England. The long-term outlook remains positive, supporting a dividend growth profile.
Steris Plc STE News Analytics from Tue, 09 Feb 2016 08:00:00 GMT to Sun, 30 Jun 2024 02:58:22 GMT -
Rating 6
- Innovation 5
- Rumor -5
